Delivery Order SPE2DB22D9353-SPE2DB25FX2BC
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $13,389.36 to DMS Pharmaceutical Group Inc. for the supply of Nplate 250 microgram vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its facility in Park Ridge, IL, with an ultimate completion date of August 11, 2025. The award was issued on July 21, 2025, and does not include a set-aside designation, allowing the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $20,091.18 by the Defense Logistics Agency (DLA) on September 8, 2025. The delivery order, which is not subject to a set-aside designation, calls for the supply of Nplate 500 microgram vials with an ultimate completion date of September 29, 2025. This award is issued under DMS Pharmaceutical Group's existing Indefinite...
- The Defense Logistics Agency issued a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 250 microgram vials of Nplate, valued at $8,368.35, with an ultimate completion date of September 12, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The company will perform the work at its Park Ridge location and deliver the pharmaceutical product to support federal...
- The Defense Logistics Agency awarded a delivery order valued at $6,697.06 to DMS Pharmaceutical Group Inc. for the supply of Nplate 500 microgram vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform work at its Park Ridge facility with an ultimate completion date of August 14, 2025. This delivery order utilizes a firm fixed-price contract type with no set-aside designation, allowing the company to compete on a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,697.06 by the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Nplate 500 microgram vials. The contract does not utilize a set-aside designation and carries an ultimate completion date of September 3, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nplate 250 microgram vials. This $1,673.67 firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes no set-aside designation and is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,347.34 by the Defense Logistics Agency on July 31, 2025, for the supply of Nplate 250 microgram vials. The delivery order carries an ultimate completion date of August 21, 2025, and requires performance at the contractor's Park Ridge, Illinois facility. This award was issued without a set-aside designation, allowing DMS...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on September 16, 2025, for the supply of Nplate 500 microgram vials, with a ceiling value of $20,091.18. This firm fixed-price delivery order is set to conclude by October 7, 2025, and represents a discrete pharmaceutical product delivery under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The contract involves no set-aside designation, and fulfillment will occur at the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $10,098.60 to DMS Pharmaceutical Group Inc. for the supply of Nplate 125 microgram vials. This firm fixed-price delivery order, issued on September 17, 2025, with an ultimate completion date of October 8, 2025, represents a specific pharmaceutical product draw against DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract carries no set-aside designation, and performance will occur at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,697.06 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Nplate 500 microgram vials. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2BCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,673.67 to DMS Pharmaceutical Group Inc. for 250 microgram vials of Nplate on August 6, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order does not utilize a set-aside designation and will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, serves as the prime contractor with no identified subcontractors on this award. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities. Nplate (romiplostim), an injectable medication used to treat immune thrombocytopenia, represents one of the specialized pharmaceutical products within the contractor's portfolio of branded and generic prescription drugs, biologics, and medical consumables. The contractor's established position as a key supplier within the federal pharmaceutical supply chain and consistent track record with the DLA demonstrates its capability to deliver critical medical supplies to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/6/25 |